Organoids can model aspects of neurodegeneration in Alzheimer's Disease and Down's Syndrome, reproducing tau hyperphosphorylation and amyloid plaque pathology. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.